1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60: 615-623.
2.
Ijsseldijk MA, Shoni M, Siegert C, Seegers J, van Engelenburg AKC, Tsai TC, Lebenthal A, Ten Broek RPG. Oncological outcomes of lobar resection, segmentectomy, and wedge resection for T1a non-small-cell lung carcinoma: a systematic review and meta-analysis. Semin Thorac Cardiovasc Surg 2020; 32: 582-590.
3.
Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, Okumura N, Yamaguchi M, Ikeda N, Wakabayashi M, Nakamura K, Fukuda H, Nakamura S, Mitsudomi T, Watanabe SI, Asamura H; West Japan Oncology Group and Japan Clinical Oncology Group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022; 399: 1607-1617.
4.
Altorki NK, Yip R, Hanaoka T, Bauer T, Aye R, Kohman L, Sheppard B, Thurer R, Andaz S, Smith M, Mayfield W, Grannis F, Korst R, Pass H, Straznicka M, Flores R, Henschke CI; I-ELCAP Investigators. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg 2014; 147: 754-762.
5.
Wald O, Sadeh BM, Bdolah-Abram T, Erez E, Shapira OM, Izhar U. Outcomes of sublobar resection vs lobectomy for invasive clinical stage T1N0 non-small-cell lung cancer: a propensity-match analysis. Cancer Rep (Hoboken) 2021; 4: e1339.
6.
Zhang Z, Feng H, Zhao H, Hu J, Liu L, Liu Y, Li X, Xu L, Li Y, Lu X, Fu X, Yang H, Liu D. Sublobar resection is associated with better perioperative outcomes in elderly patients with clinical stage I non-small cell lung cancer: a multicenter retrospective cohort study. J Thorac Dis 2019; 11: 1838-1848.
7.
Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5 Suppl): e278S-e313S.
8.
Holbek BL, Petersen RH, Hansen HJ. Is it safe to perform completion lobectomy after diagnostic wedge resection using video-assisted thoracoscopic surgery?. Gen Thorac Cardiovasc Surg 2016; 64: 203-208.
9.
Wang Y, Wang R, Zheng D, Han B, Zhang J, Zhao H, Luo J, Zheng J, Chen T, Huang Q, Sun Y, Chen H. The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation. J Cancer Res Clin Oncol 2017; 143: 2095-2104.
10.
Takamori S, Oizumi H, Suzuki J, Suzuki K, Watanabe H, Sato K. Completion lobectomy after anatomical segmentectomy. Interact Cardiovasc Thorac Surg 2022; 34: 1038-1044.
11.
Warwick R, Shackcloth M, Mediratta N, Page R, McShane J, Shaw M, Poul- lis M. Female sex and long-term survival post curative resection for non-small-cell lung cancer. Eur J Cardiothorac Surg 2013; 44: 624-630.
12.
Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, Okumura N, Yamaguchi M, Ikeda N, Wakabayashi M, Nakamura K, Fukuda H, Nakamura S, Mitsudomi T, Watanabe SI, Asamura H; West Japan Oncology Group and Japan Clinical Oncology Group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022; 399: 1607-1617.
13.
Reveliotis K, Kalavrouziotis G, Skevis K, Charpidou A, Trigidou R, Syrigos K. Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma. Oncol Rev 2014; 8: 234.
14.
Stamatis G, Leschber G, Schwarz B, Brintrup DL, Ose C, Weinreich G, Passlick B, Hecker E, Kugler C, Dienemann H, Krbek T, Eggeling S, Hatz R, Müller MR, Weder W, Aigner C, Jöckel KH. Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system). Lung Cancer 2019; 138: 19-26.
15.
Liu YW, Kao CN, Chiang HH, Lee JY, Li HP, Chang PC, Chou SH. Pulmonary completion lobectomy after segmentectomy: an integrated analysis of perioperative outcomes. Thorac Cancer 2022; 13: 2331-2339.
16.
Nomori H, Mori T, Izumi Y, Kohno M, Yoshimoto K, Suzuki M. Is completion lobectomy merited for unanticipated nodal metastases after radical segmentectomy for cT1 N0 M0/pN1-2 non-small cell lung cancer? J Thorac Cardiovasc Surg 2012; 143: 820-824.
17.
Jones GD, Caso R, Choe G, Tan KS, Connolly JG, Dycoco J, Molena D, Park BJ, Huang J, Adusumilli PS, Bott MJ, Downey RJ, Travis WD, Jones DR, Rocco G. Intentional segmentectomy for clinical T1 N0 non-small cell lung cancer: survival differs by segment. Ann Thorac Surg 2021; 111: 1028-1035.
18.
Luo X, Hayanga JWA, Mehaffey JH, Lamb J, Campbell S, Reddy S, Badhwar V, Toker A. Clinical stage IA non-small cell lung cancer with occult pathologic N1 and N2 disease after segmentectomy: does a completion lobectomy justify? Eur J Cardiothorac Surg 2024; 66: ezae415.
19.
Chan EG, Chan PG, Mazur SN, Normolle DP, Luketich JD, Landreneau RJ, Schuchert MJ. Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer. J Thorac Cardiovasc Surg 2021; 161: 1639-1648.e2.
20.
Iwai Y, Tasoudis P, Agala CB, Khoury AL, O’Hara Garcia DN, Long JM. Lobectomy versus segmentectomy in patients with T1N2 non-small cell lung cancer: an analysis of the National Cancer Database. JTCVS Open 2024; 21: 304-312.
